Repligen
RGEN
163 hedge funds and large institutions have $641M invested in Repligen in 2014 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 49 increasing their positions, 58 reducing their positions, and 18 closing their positions.
150% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 18
87% more capital invested
Capital invested by funds: $342M → $641M (+$298M)
55% more call options, than puts
Call options by funds: $6.73M | Put options by funds: $4.34M
20% more funds holding
Funds holding: 136 → 163 (+27)
16% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 58
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$14.8M |
| 2 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$10.6M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$7.11M |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.08M |
| 5 |
VAM
Visium Asset Management
New York
|
-$5.7M |
RGEN Hedge Fund Activity: Q2 2014 in Review
163 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q2 2014, worth a combined $641M — up 87% from $342M a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new RGEN positions and 18 closed out — a net gain of 27 holders — while 49 added to existing stakes and 58 trimmed.
The largest buyer was Conestoga Capital Advisors, opening a new position worth an estimated $18.6M. The largest seller was Millennium Management, exiting entirely with an estimated $14.8M sold.
- 163 institutional investors held Repligen (RGEN) as of Q2 2014, up from 136 in Q1 2014.
- Funds reported $641M of Repligen stock for Q2 2014, up 87% quarter-over-quarter.
- 45 funds opened new Repligen positions in Q2 2014 and 18 closed out, a net change of +27 holders.
- The largest Repligen buyer in Q2 2014 was Conestoga Capital Advisors, an estimated $18.6M added.
- The largest Repligen seller in Q2 2014 was Millennium Management, an estimated $14.8M sold.
Based on aggregated 13F filings for Q2 2014.